PAPER Gendron TF, Bieniek KF, Zhang YJ, Jansen-West K, Ash PE, Caulfield T, Daughrity L, Dunmore JH, Castanedes-Casey M, Chew J, Cosio DM, van Blitterswijk M, Lee WC, Rademakers R, Boylan KB, Dickson DW, Petrucelli L

Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS.

Acta Neuropathol. 2013 Oct 16; PubMed: 24129584

PAPER Knippenberg S, Sipos J, Thau-Habermann N, Körner S, Rath KJ, Dengler R, Petri S

Altered Expression of DJ-1 and PINK1 in Sporadic ALS and in the SOD1G93A ALS Mouse Model.

J Neuropathol Exp Neurol. 2013 Nov;72(11):1052-61. PubMed: 24128678

PAPER Bergeron M, Motter R, Tanaka P, Fauss D, Babcock M, Chiou SS, Nelson S, San Pablo F, Anderson JP

In Vivo Modulation of Polo-Like Kinases (PLK) Supports a Key Role for PLK2 in Ser129 α-Synuclein Phosphorylation in Mouse Brain.

Neuroscience. 2013 Oct 12;256C:72-82. PubMed: 24128992

PAPER Bame M, Grier RE, Needleman R, Brusilow WS

Amino Acids as biomarkers in the SOD1(G93A) mouse model of ALS.

Biochim Biophys Acta. 2013 Oct 12;1842(1):79-87. PubMed: 24129262

PAPER Laferrière F, Tixador P, Moudjou M, Chapuis J, Sibille P, Herzog L, Reine F, Jaumain E, Laude H, Rezaei H, Béringue V

Quaternary structure of pathological prion protein as a determining factor of strain-specific prion replication dynamics.

PLoS Pathog. 2013 Oct;9(10):e1003702. PubMed: 24130496

PAPER Büttner S, Habernig L, Broeskamp F, Ruli D, Vögtle FN, Vlachos M, Macchi F, Küttner V, Carmona-Gutierrez D, Eisenberg T, Ring J, Markaki M, Taskin AA, Benke S, Ruckenstuhl C, Braun R, Van den Haute C, Bammens T, van der Perren A, Fröhlich KU, Winderickx J, Kroemer G, Baekelandt V, Tavernarakis N, Kovacs GG, Dengjel J, Meisinger C, Sigrist SJ, Madeo F

Endonuclease G mediates α-synuclein cytotoxicity during Parkinson's disease.

EMBO J. 2013 Nov 27;32(23):3041-54. PubMed: 24129513

PAPER Berry DB, Lu D, Geva M, Watts JC, Bhardwaj S, Oehler A, Renslo AR, Dearmond SJ, Prusiner SB, Giles K

Drug resistance confounding prion therapeutics.

Proc Natl Acad Sci U S A. 2013 Oct 29;110(44):E4160-9. PubMed: 24128760

PAPER Bagheri M, Rezakhani A, Nyström S, Turkina MV, Roghani M, Hammarström P, Mohseni S

Amyloid Beta1-40-Induced Astrogliosis and the Effect of Genistein Treatment in Rat: A Three-Dimensional Confocal Morphometric and Proteomic Study.

PLoS One. 2013;8(10):e76526. PubMed: 24130779

PAPER Gonzalez MT, Kirkevold M

Benefits of sensory garden and horticultural activities in dementia care: a modified scoping review.

J Clin Nurs. 2013 Oct 15; PubMed: 24128125

PAPER Hales CM, Rees H, Seyfried NT, Dammer EB, Duong DM, Gearing M, Montine TJ, Troncoso JC, Thambisetty M, Levey AI, Lah JJ, Wingo TS

Abnormal gephyrin immunoreactivity associated with Alzheimer disease pathologic changes.

J Neuropathol Exp Neurol. 2013 Nov;72(11):1009-15. PubMed: 24128675

PAPER Sun Y, Chen J, Chen X, Huang L, Li X

Inhibition of cholinesterase and monoamine oxidase-B activity by Tacrine-Homoisoflavonoid hybrids.

Bioorg Med Chem. 2013 Dec 1;21(23):7406-17. PubMed: 24128814

PAPER Siman R, Lin YG, Malthankar-Phatak G, Dong Y

A rapid gene delivery-based mouse model for early-stage Alzheimer disease-type tauopathy.

J Neuropathol Exp Neurol. 2013 Nov;72(11):1062-71. PubMed: 24128676

PAPER Kim HJ, Kim W, Kong SY

Antidepressants for neuro-regeneration: from depression to Alzheimer's disease.

Arch Pharm Res. 2013 Nov;36(11):1279-90. PubMed: 24129616

PAPER Chiu MJ, Chen YF, Chen TF, Yang SY, Yang FP, Tseng TW, Chieh JJ, Chen JC, Tzen KY, Hua MS, Horng HE

Plasma tau as a window to the brain-negative associations with brain volume and memory function in mild cognitive impairment and early Alzheimer's disease.

Hum Brain Mapp. 2014 Jul;35(7):3132-42. Epub 2013 Oct 15 PubMed: 24129926

PAPER Dickerson BC, Wolk DA,

Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau.

Front Aging Neurosci. 2013;5:55. PubMed: 24130528